FDA Revises Implementation Dates for Disease Risk Reduction Guidelines
February 01, 2025
February 01, 2025
WASHINGTON, Feb. 1 (TNSFR) -- The Food and Drug Administration (FDA) has revised the implementation dates for two important guidance documents aimed at reducing the risk of disease transmission through human cells, tissues, and cellular and tissue-based products (HCT/Ps).
The documents, entitled "Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis" and "Recommendations to Reduce the Risk of Transmission of Mycobacterium Tubercu . . .
The documents, entitled "Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis" and "Recommendations to Reduce the Risk of Transmission of Mycobacterium Tubercu . . .